Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.
Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, Kim YK, Inoue T, Lim L, Masdrakis V, Menchón JM, Miguel EC, Möller HJ, Nardi AE, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein DJ, Tsai SJ, Van Ameringen M, Vasileva A, Wang Z, Zohar J. Bandelow B, et al. Among authors: fineberg na. World J Biol Psychiatry. 2023 Feb;24(2):79-117. doi: 10.1080/15622975.2022.2086295. Epub 2022 Jul 28. World J Biol Psychiatry. 2023. PMID: 35900161
Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
Baldwin D, Fineberg N, Montgomery S. Baldwin D, et al. Int Clin Psychopharmacol. 1991 Spring;6(1):51-8. doi: 10.1097/00004850-199100610-00007. Int Clin Psychopharmacol. 1991. PMID: 1906498 No abstract available.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU; British Association for Psychopharmacology. Baldwin DS, et al. Among authors: fineberg na. J Psychopharmacol. 2005 Nov;19(6):567-96. doi: 10.1177/0269881105059253. J Psychopharmacol. 2005. PMID: 16272179
Escitalopram prevents relapse of obsessive-compulsive disorder.
Fineberg NA, Tonnoir B, Lemming O, Stein DJ. Fineberg NA, et al. Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):430-9. doi: 10.1016/j.euroneuro.2006.11.005. Epub 2007 Jan 19. Eur Neuropsychopharmacol. 2007. PMID: 17240120 Clinical Trial.
Obsessive-compulsive disorder: boundary issues.
Fineberg NA, Saxena S, Zohar J, Craig KJ. Fineberg NA, et al. CNS Spectr. 2007 May;12(5):359-64, 367-375. doi: 10.1017/s1092852900021167. CNS Spectr. 2007. PMID: 17514081 Review.
248 results